Advertisement

Topics

Pyxis Discovery B.V. Company Profile

04:20 EDT 22nd September 2017 | BioPortfolio

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and selecting compound libraries facilitates a rapid and efficient lead discovery process, yielding lead compounds with excellent pharmacological profiles. Pyxis Discovery uses proprietary software algorithms for compound design and selection and a Global Supplier Database of nearly all commercially available screening compounds to provide its clients with screening libraries that are tailored to their specific needs. Furthermore, Pyxis Discovery offers high quality compound libraries off the shelf. Pyxis Discovery is headquartered in the Netherlands and has a worldwide presence with also an office in Boston, Massachusetts and representation in Japan.


News Articles [452 Associated News Articles listed on BioPortfolio]

Consortium Applies Quantum Computing to Drug Discovery for Neurological Diseases

NewsMolecular comparison is a crucial part of early-phase drug design and discovery.

Thun Hospital use BD's Pyxis MedStation™ system to automate medication management

BD (Becton, Dickinson and Company), a leading global medical technology company, today announced the STS AG Hospital in Thun, Switzerland has become the first hospital in the world to introduce a full...

Sygnature Discovery partners on pancreatic cancer research

Sygnature Discovery, which claims to be the UK’s largest independent drug discovery expert and research…

Target class drug discovery

Selection of molecular targets based on disease understanding is a dominant paradigm in drug discovery. We argue that a focus on classes of targets with central roles in biology provides a complimenta...

Almac Discovery y Debiopharm International SA anuncian el desarrollo de un nuevo inhibidor Wee-1

Almac Discovery ( http://www.almacgroup.com/discovery), una compañía biofarmacéutica centrada en el descubrimiento e identificación de terapéuticos innovadores para el tratamiento del cáncer, ...

Dementia Discovery Fund to invest $5m in Cerevance to advance Alzheimer’s treatment

SV Life Sciences-managed Dementia Discovery Fund (DDF), which develops disease modifying drugs for dementia, has announced a $5m investment in the initial financing round of start-up drug discovery co...

BioAscent Discovery Appoints New CEO And Announces Plans To Expand Discovery Services Offering

  Life Sciences Jobs   ...

Daiichi Sankyo in Drug Discovery Collaboration

Enters cancer research partnership with Max Planck Innovation and Lead Discovery Center

PubMed Articles [680 Associated PubMed Articles listed on BioPortfolio]

Role of Academic Drug Discovery in the Quest for New CNS Therapeutics.

There was a greater than 50% decline in central nervous system (CNS) drug discovery and development programs by major pharmaceutical companies from 2009 to 2014. This decline was paralleled by a rise ...

Advances in epilepsy gene discovery and implications for epilepsy diagnosis and treatment.

Epilepsy genetics is shifting from the academic pursuit of gene discovery to a clinical discipline based on molecular diagnosis and stratified medicine. We consider the latest developments in epilepsy...

The Utility of Target-Based Discovery.

18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.

To evaluate if the new Discovery Molecular Insights (DMI) PET/CT scanner provides equivalent results compared to the standard of care PET/CT scanners (GE Discovery 600 or GE Discovery 690) used in our...

Three-Dimensional Cell Culture: A Rapidly Emerging Approach to Cellular Science and Drug Discovery.

Clinical Trials [137 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma

The purpose of the study is to better understand the function of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, our propose ...

Retrospective Study on the Evaluation of Intra-disc Infiltration in the Active Disc Disease

Active discopathies or MODIC 1, are a diagnostic entity discovery with the contribution of MRI in which the first cases were described by Dr. Michael MODIC in 1988. It is characterized by ...

Companies [1062 Associated Companies listed on BioPortfolio]

Pyxis Discovery B.V.

The ambition of Pyxis Discovery is to be the preferred chemistry service provider for companies that are active in small molecule drug discovery. Pyxis Discovery's Smart approach of designing and ...

Pyxis Discovery

Pyxis Discovery offers chemistry-based drug discovery services to the global pharmaceutical industry and develops products and services on the basis of computational chemistry. The activities of Pyxis...

Cardinal Health

Cardinal Health, we understand health care and its unique challenges. When health care leaders called for a better way to safely dispense medications, we were the first to answer with the revolutionar...

Discovery Health

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets, including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and ...

Sprout Group

Founded in 1969, the Sprout Group raised its first venture fund of $12 million more than 30 years ago. Since then, Sprout has financed more than 350 companies whose combined revenues now exceed $50 bi...

More Information about "Pyxis Discovery B.V." on BioPortfolio

We have published hundreds of Pyxis Discovery B.V. news stories on BioPortfolio along with dozens of Pyxis Discovery B.V. Clinical Trials and PubMed Articles about Pyxis Discovery B.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pyxis Discovery B.V. Companies in our database. You can also find out about relevant Pyxis Discovery B.V. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record